Exagen Inc. Rings the Opening Bell in Celebration of its IPO
ABOUT THIS EVENT
Exagen Inc. (Nasdaq: XGN), dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, Ron Rocca, President & CEO, rang the Opening Bell.